.:. Inovasi Eukaliptus sebagai Antivirus Covid-19 oleh Balitbang Pertanian - Insight With Desi Anwar

1. A pneumonia outbreak associated with a new coronavirus of probable bat origin

2. A new coronavirus associated with human respiratory disease in China

3. Latest updates on the coronavirus outbreak

4. What you need to know about the Wuhan coronavirus

5. Coronavirus outbreak: What�s next?

6. China�s response to a novel coronavirus stands in stark contrast to the 2002 SARS outbreak response

7. Rapid outbreak response requires trust

8. A mouse model for MERS coronavirus-induced acute respiratory distress syndrome

9. Precision mouse models with expanded tropism for human pathogens

10. Dampened NLRP3-mediated inflammation in bats and implications for a special viral reservoir host

11. SKP2 attenuates autophagy through Beclin1-ubiquitination and its inhibition reduces MERS-Coronavirus infection

12. Early events during human coronavirus OC43 entry to the cell

13. Structural basis for human coronavirus attachment to sialic acid receptors

14. Structures of MERS-CoV spike glycoprotein in complex with sialoside attachment receptors

15. Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors

16. Structural definition of a neutralization epitope on the N-terminal domain of MERS-CoV spike glycoprotein

17. Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis

18. Functional analysis of potential cleavage sites in the MERS-coronavirus spike protein

19. ISG15 in antiviral immunity and beyond

20. REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes

21. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV

22. SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral target

23. Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations

24. Evaluation of a recombination-resistant coronavirus as a broadly applicable, rapidly implementable vaccine platform

25. Development and Evaluation of a Multiplexed Immunoassay for Simultaneous Detection of Serum IgG Antibodies to Six Human Coronaviruses

26. Deubiquitylating enzymes and drug discovery: emerging opportunities

27. Clinical metagenomics

28. Passive immunotherapy of viral infections: 'super-antibodies' enter the fray

29. Origin and evolution of pathogenic coronaviruses

30. A new twenty-first century science for effective epidemic response

31. Precision epidemiology for infectious disease control

32. Tracking virus outbreaks in the twenty-first century

33. Modelling microbial infection to address global health challenges

34. Emerging viral diseases from a vaccinology perspective: preparing for the next pandemic

35. Pathways to zoonotic spillover

36. Towards a genomics-informed, real-time, global pathogen surveillance system

37. The phylogenomics of evolving virus virulence

38. Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin

39. Characterizing the dynamics underlying global spread of epidemics

40. Comparative Analysis of Eleven Healthcare-Associated Outbreaks of Middle East Respiratory Syndrome Coronavirus (Mers-Cov) from 2015 to 2017

41. Infection Prevention Measures for Surgical Procedures during a Middle East Respiratory Syndrome Outbreak in a Tertiary Care Hospital in South Korea

42. Attenuation of replication by a 29 nucleotide deletion in SARS-coronavirus acquired during the early stages of human-to-human transmission

43. Origin and evolution of pathogenic coronaviruses

44. Structural basis for human coronavirus attachment to sialic acid receptors

45. Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors

46. SKP2 attenuates autophagy through Beclin1-ubiquitination and its inhibition reduces MERS-Coronavirus infection

47. Structural definition of a neutralization epitope on the N-terminal domain of MERS-CoV spike glycoprotein

48. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV

49. Structures of MERS-CoV spike glycoprotein in complex with sialoside attachment receptors

50. Dampened NLRP3-mediated inflammation in bats and implications for a special viral reservoir host

51. Precision mouse models with expanded tropism for human pathogens

52. Tracking virus outbreaks in the twenty-first century

53. A new twenty-first century science for effective epidemic response

54. Outbreak of a novel coronavirus

55. Global site-specific analysis of glycoprotein N-glycan processing

56. Bat tolerance to viral infections

57. Acute respiratory distress syndrome

58. �On the bat�s back I do fly�

59. Decoding type I and III interferon signalling during viral infection

60. An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections

61. IFITM3 directly engages and shuttles incoming virus particles to lysosomes

62. Prisoners of war � host adaptation and its constraints on virus evolution

63. Studying human lung infection in mice

64. Autophagy during viral infection � a double-edged sword

65. A CRISPR screen identifies IFI6 as an ER-resident interferon effector that blocks flavivirus replication

66. Capturing sequence diversity in metagenomes with comprehensive and scalable probe design

67. Liver sinusoidal endothelial cells � gatekeepers of hepatic immunity

68. Improving preparedness for the next flu pandemic

69. Norbert Bischofberger

70. Modeling human lung infections in mice

71. Respiratory syncytial virus entry and how to block it

72. Inflammation induced by influenza virus impairs human innate immune control of pneumococcus

73. Crystal structure of the natural anion-conducting channelrhodopsin Gt ACR1

74. The virome hunters

75. Expanded skin virome in DOCK8-deficient patients

76. Dilated cardiomyopathy

77. Transcriptome networks identify mechanisms of viral and nonviral asthma exacerbations in children

78. Viral RNA structure-based strategies to manipulate translation

79. The successes and future prospects of the linear antisense RNA amplification methodology

80. Lysosomes as a therapeutic target

81. Counter-regulatory renin�angiotensin system in cardiovascular disease

82. Nociceptor sensory neurons suppress neutrophil and ?? T cell responses in bacterial lung infections and lethal pneumonia

83. Defective viral genomes are key drivers of the virus�host interaction